Carter Eric G 4
4 · ALDER BIOPHARMACEUTICALS INC · Filed Apr 25, 2018
Insider Transaction Report
Form 4
Carter Eric G
Interim Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-04-23+75,000→ 75,000 totalExercise: $13.65Exp: 2028-04-22→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]If the Reporting person remains continuously employed with the Issuer in good standing through the earlier to occur of (i) the twelve (12)-month anniversary of April 23, 2018 and (ii) the date that a new Chief Medical Officer begins employment with the Issuer (such earlier date, the "End Date"), 100% of the shares subject to the option will immediately vest on the End Date.